Risk of bias (quality) assessment Two authors (AJ and SS-B) independently assessed the risk of bias of the trials according to version 2.0 of the Cochrane tool for risk of bias assessment (Reference Higgins, Thomas and Chandler13)
These cases have been consolidated into a federal multidistrict litigation (MDL) in the Eastern District of Pennsylvania, allowing courts to manage the increasing number of claims efficiently
Until the FDA completes the next steps, patients and prescribers should treat the result as an important recommendationnot a completed policy change
If approved, receive prescriptions and enroll in an ongoing virtual followup and messaging plan
We believe that when you have access to clean, bioavailable nutrients, you are empowered to build a routine that truly supports your life
Groundbreaking occurred in 2023, with initial output expected late 2026 and volume ramp through 2028